H20.049
Secondary noninfectious iridocyclitis, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary noninfectious iridocyclitis, also known as inflammation of the iris and ciliary body in the eye, occurs when these structures become inflamed due to causes other than infections. This condition affects the uveal tract, which is rich in blood vessels, and can lead to vision problems if not properly managed. The term 'secondary' indicates that the inflammation is a result of another underlying condition or factor, rather than occurring independently. When no specific origin is identified, the condition is categorized as unspecified eye in ICD-10 code H20.049. Recognizing this condition is vital because it can cause significant discomfort and, in some cases, lead to long-term vision impairment if left untreated.
Causes & Symptoms
Clinical Causes: Autoimmune disorders, such as rheumatoid arthritis or sarcoidosis Trauma or injury to the eye Previous eye surgeries or procedures Certain medications or systemic diseases Chronic eye conditions that trigger inflammatory responses Unknown or idiopathic factors
Key Symptoms: Eye redness, often localized around the iris Pain or tenderness in the eye Photophobia, or sensitivity to light Blurred or decreased vision A sensation of heaviness or mild discomfort in the eye Unequal pupil size or abnormal pupil response in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis begins with a comprehensive eye examination by an ophthalmologist. The healthcare provider performs slit-lamp examinations to observe inflammation, checks the pupil response, and assesses intraocular pressure. Additional tests may include ultrasound biomicroscopy or fundus examination to evaluate other parts of the eye and rule out infections or structural abnormalities. Medical history is reviewed to identify any underlying autoimmune or systemic diseases. Since the condition is categorized as unspecified, specific causes may not always be identified, requiring ongoing monitoring and evaluation.
Treatment Protocols: Management involves reducing inflammation and preventing complications. Common treatment options include topical corticosteroids to control inflammation, eye drops to dilate the pupil and relieve pain, and sometimes systemic medications for underlying conditions. Regular follow-ups are important to monitor the eye's response to treatment and adjust therapies as necessary. Patients are advised to protect their eyes from bright light, avoid trauma, and adhere to prescribed treatment regimens. In some cases, corticosteroid injections or immunosuppressive therapies might be recommended for persistent or severe cases. Early intervention aims to preserve vision and minimize the risk of long-term damage.
Clinical Advice & FAQs
Billing Guidance
Is H20.049 a billable ICD-10 code?
Yes, H20.049 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H20.049?
Clinical documentation must specify the nature of Secondary noninfectious iridocyclitis, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference